Listar por tema "beta interferon"

Mostrando ítems 1-2 de 2

CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis

Menezes, Soraya Maria; Decanine, Daniele; Brassat, David; Khouri, Ricardo; Schnitman, Saul V.; Kruschewsky, Ramon; López, Giovanni; Alvarez, Carolina; Talledo Albujar, Michael John; Gotuzzo Herencia, José Eduardo; Vandamme, Anne-Mieke; Galvão-Castro, Bernardo; Liblau, Roland; Weyenbergh, Johan Van (BioMed Central, 2014)

Background: Human T-cell lymphotropic virus (HTLV-1) is the causative agent of the incapacitating, neuroinflammatory disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Currently, there are no ...
Latin American algorithm for treatment of relapsing-remitting multiple sclerosis using disease-modifying agents

Finkelsztejn, A.; Gabbai, A.A.; Fragoso, Y.D.; Carrá, A.; Macías-Islas, M.A.; Arcega-Revilla, R.; García-Bonitto, J.; Oehninger-Gatti, C.L.; Orozco-Escobar, G.; Tarulla, A.; Vergara, F.; Vizcarra-Escobar, Darwin (SP Academia Brasileira de Neurologia, 2012)

Objective: It is estimated that circa 50,000 individuals have relapsing-remitting multiple sclerosis in Latin America. European and NorthAmerican algorithms for the treatment of multiple sclerosis do not foresee our regional ...

Buscar en el Repositorio